Outbound Sales for Biotech Companies
Biotech sales cycles are long, technical, and relationship-dependent. We handle personalized outreach to pharma partners, research institutions, and clinical buyers -- so your team can focus on science and deal execution. Live in 5 business days.
The problem
Biotech companies face a unique outbound challenge: your buyers are PhD-level scientists, clinical directors, and pharma executives who ignore generic pitches. Sales cycles span 12-24 months, requiring multiple touchpoints across research, regulatory, and commercial teams. Most outbound falls flat because it lacks scientific credibility or fails to address specific therapeutic areas and development stages. Your internal team is stretched thin between fundraising, clinical trials, and product development -- leaving pipeline generation reactive and inconsistent. Meanwhile, competitors with established pharma relationships are locking up partnership deals and licensing agreements.
Why outbound works for biotech
Inbound doesn't work when your ideal partners are running clinical trials and developing competing therapies. Relying on conferences and warm introductions caps your pipeline at 2-3 opportunities per quarter. Outbound lets you reach pharma BD teams, research institutions, and clinical decision-makers before they engage competitors. Done right, personalized outreach generates 8-15 qualified conversations per month with organizations that match your therapeutic focus, development stage, and partnership needs. The companies closing $50M+ licensing deals aren't waiting for inbound leads.
Who we target
Pharma and research buyers evaluate three things: scientific credibility, clinical data quality, and regulatory pathway clarity. Your outreach needs to reference specific therapeutic areas, mechanism of action, and competitive landscape -- not generic biotech marketing. They want to understand where you are in development, what partnerships you're seeking, and how you fit their portfolio strategy. Credible outreach opens doors. Generic messaging from Apollo or LinkedIn templates gets deleted. The difference is a team that understands drug development stages and can articulate your value in the language pharma BD teams actually use.
How we approach biotech outbound
We build targeted lists of pharma business development teams, research institutions, and clinical decision-makers aligned with your therapeutic area. Outreach references specific drug pipelines, therapeutic focus, and partnership models your prospects care about. Every warm reply gets a call within 60 minutes from an operator who understands your science and can qualify partnership fit. We use dedicated sending domains -- never your company domain -- and integrate with your CRM so every conversation is tracked. No AI bots. No generic templates. Just personalized, multi-channel outreach that generates qualified pipeline.
What to expect
Biotech clients typically see 6-12 qualified partnership conversations per month within 60 days. Reply rates run 7-14% vs the 1-3% industry average for cold outreach. Average cost per qualified meeting is $300-600 -- compare that to $15K+ for a single industry conference with no guaranteed meetings. One licensing deal or research partnership pays for years of outbound. We track every metric: emails sent, replies, meetings booked, and pipeline created. Bi-weekly reports show exactly what's working and where opportunities are developing.
Frequently asked questions
We build verified contact lists of decision-makers at biotech companies, write personalized outreach sequences specific to your market, and run multichannel campaigns across email and LinkedIn. Every warm reply is called within 60 minutes. The system is live within 5 business days.
Biotech clients typically see reply rates of 7-14% and 6-12 meetings booked per month per month. Pipeline value added in the first 90 days ranges from $2M-8M, depending on your deal size and market.
We target the decision-makers who buy what you sell: VP of Business Development, Director of Research & Development, Head of Strategic Partnerships, and similar titles. Each campaign is tailored to the specific titles, industries, and company sizes that match your ideal customer profile.
Ready to build your biotech outbound system?
Book a 15-minute call. We'll discuss your therapeutic focus, ideal partners, and partnership goals. If it's a fit, we're live in 5 business days with outreach running and a dedicated operator handling every warm reply.